Specified populations tend to be more susceptible to the adverse outcomes of synthetic cannabinoids. People with pre-present psychiatric disorders, such as schizophrenia and epilepsy, are at higher hazard mainly because of the probable for SCs to precipitate psychiatric and neurologic Problems.